Hasija Amit

Hasija Amit is listed in filings as CFO & EVP of Corp. Development at Milestone Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Feb 5, 2026, including sale activity. Recent filings connect the profile to Milestone Pharmaceuticals Inc. (MIST). The current snapshot covers public activity from Jan 29, 2025 to Feb 5, 2026. Reported amounts are shown as $401.9K to $23.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.